SUBSCRIBE
SUBSCRIBE

BioSpace Insights

The BioSpace Insights team performs research and analysis on industry trends for BioSpace and clients, producing industry reports, podcasts, events and articles.

Employer Resources
Report: 2024 Employment Outlook
BioSpace’s Employment Outlook report investigates anticipated job search activity and hiring outlook in 2024 as well as how the current workforce is currently faring
January 19, 2024
 · 
1 min read
 · 
BioSpace Insights
Deals
Alternative funding strategies to discuss at JPM with Halia Therapeutics, the ADDF and Triumvira Immunologics
BioSpace and guests from Halia Therapeutics, Triumvira Immunologics and the Alzheimer’s Drug Discovery Foundation discuss alternative financing strategies to consider for 2024. Listen now.
January 4, 2024
 · 
1 min read
 · 
BioSpace Insights
What VCs look for when investing with MPM Capital, Endeavor Venture Fund and Two Bear Capital
How can startup leaders support long-term sustainable growth and investment? BioSpace’s Lori Ellis speaks with venture capital guests Ansbert Gadicke, Martin Gershon and Mike Goguen for their advice and recommendations on how biopharma startups should approach funding.
December 19, 2023
 · 
1 min read
 · 
BioSpace Insights
Deals
What VCs really think of the market right now with MPM Capital, Endeavor and Two Bear Capital
What needs to happen for funding in biopharma to bounce back? BioSpace’s Lori Ellis discusses the macroeconomic environment and biopharma funding outlook with venture capital guests Ansbert Gadicke, Martin Gershon and Mike Goguen.
December 14, 2023
 · 
1 min read
 · 
BioSpace Insights
Deals
Webinar: Alternative Funding Strategies to Discuss at JPM
BioSpace and guests from Halia Therapeutics, Triumvira Immunologics and the Alzheimer’s Drug Discovery Foundation will discuss alternative financing strategies to consider for 2024. Watch now.
December 12, 2023
 · 
4 min read
 · 
BioSpace Insights
Drug Development
Fast and furious evolution: How to ensure AI is catalyst for positive societal change with Microsoft and IQVIA
In this episode we dive into regulation, real-time management, and AI’s various applications and how it can streamline different processes with guests from Microsoft and IQVIA.
December 12, 2023
 · 
1 min read
 · 
BioSpace Insights
Employer Resources
Integrating AI in life sciences to change employee behavior with Microsoft and IQVIA
In this episode, hear from senior leaders at Microsoft and IQVIA to get their take on how generative AI is impacting productivity, employee engagement and how to mitigate risks.
December 7, 2023
 · 
1 min read
 · 
BioSpace Insights
Drug Development
Artificial Intelligence, Part 3: Improving Communication to Impact Patient Behavior
In this third episode of Denatured’s series on AI in drug discovery, we discuss patient behavior and its influence on clinical trials and AI models with guests from GSK, IQVIA, Exelixis and DataHow.
December 5, 2023
 · 
1 min read
 · 
BioSpace Insights
Drug Development
Artificial Intelligence, Part 2: Human Interaction, Liability, and Patient Safety
Listen to this in-depth discussion on how AI can help identify end-to-end data weaknesses, as well as broader implications regarding the inevitability of human interaction, with guests from GSK, IQVIA, Exelixis and DataHow.
November 30, 2023
 · 
1 min read
 · 
BioSpace Insights
Drug Development
Upstream Bio’s Quest for Effective Best-in-Class Treatments for Allergic Inflammation
Advancements in asthma biologics spell future hope for patients with severe asthma.
November 22, 2023
 · 
6 min read
 · 
BioSpace Insights
Drug Development
Artificial Intelligence, Part 1: Bias, Access, ROI, Potential Success and Failure
This is part one of a discussion focused upon data bias, accuracy, access and the future of AI in drug development. Topics explored are ROI, human bias, data challenges, data management plans, and human expertise.
November 15, 2023
 · 
1 min read
 · 
Lori Ellis
Drug Development
Harnessing Social Media for Clinical Trial Recruitment
A failed rare disease clinical trial brings social media expertise to the pharma industry and patient recruitment: A discussion with Bryan Manning, founder of Clinical Enrollment and Two Blind Brothers
November 8, 2023
 · 
6 min read
 · 
BioSpace Insights
Drug Development
Optimizing Biomarker Assays to Bridge the Clinical Trial Participation Gap
High multiplexed patient-centric assays could reduce patient burden
October 25, 2023
 · 
3 min read
 · 
BioSpace Insights
Drug Development
Navigating the Challenges of Clinical Trial Design
Protocol design optimization and timely engagement of regulators are the crux of optimized, patient-centric clinical trials.
October 25, 2023
 · 
6 min read
 · 
BioSpace Insights
Business
JLABS @ NYC Celebrates Its 5th Year in the Big Apple
Uniting thought leaders across the life sciences landscape, JLABS @ NYC rejoices in five years of catalyzing startups.
October 23, 2023
 · 
3 min read
 · 
BioSpace Insights
Load More